{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:54:59Z","timestamp":1776722099525,"version":"3.51.2"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"DOI":"10.1007\/s12017-026-08925-w","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:28:06Z","timestamp":1776720486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Naftidrofuryl Exerts Neuroprotective Effects in a Rotenone-Induced Rat Model of Parkinson\u2019s Disease Through Modulation of PINK1\/Parkin and ER Stress Pathways"],"prefix":"10.1007","volume":"28","author":[{"given":"Saad Misfer","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-7549","authenticated-orcid":false,"given":"Ehab A. M.","family":"El-Shoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna A.","family":"Abdelzaher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souty M. Z.","family":"Sharkawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Atwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha Hosni","family":"Morsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel A.","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"8925_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed, S., Kwatra, M., Ranjan Panda, S., Murty, U. S. N., & Naidu, V. G. M. (2021). Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of Parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain, Behavior, and Immunity, 91, 142\u2013158. https:\/\/doi.org\/10.1016\/j.bbi.2020.09.017","journal-title":"Brain, Behavior, and Immunity"},{"issue":"6","key":"8925_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jsps.2022.03.005","volume":"30","author":"S Ahmed","year":"2022","unstructured":"Ahmed, S., El-Sayed, M. M., Kandeil, M. A., & Khalaf, M. M. (2022). Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of \u03b1-synuclein and Parkin levels in rotenone-induced Parkinson\u2019s disease in rats. Saudi Pharmaceutical Journal, 30(6), 863\u2013873. https:\/\/doi.org\/10.1016\/j.jsps.2022.03.005","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"3","key":"8925_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.amjms.2017.05.002","volume":"354","author":"D Aksoy","year":"2017","unstructured":"Aksoy, D., Solmaz, V., \u00c7avu\u015fo\u011flu, T., Meral, A., Ate\u015f, U., & Erba\u015f, O. (2017). Neuroprotective effects of Eexenatide in a rotenone-induced rat model of Parkinson\u2019s disease. American Journal of the Medical Sciences, 354(3), 319\u2013324. https:\/\/doi.org\/10.1016\/j.amjms.2017.05.002","journal-title":"American Journal of the Medical Sciences"},{"issue":"1","key":"8925_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12993-025-00279-w","volume":"21","author":"DD \u00c1lvarez-Luqu\u00edn","year":"2025","unstructured":"\u00c1lvarez-Luqu\u00edn, D. D., Gonz\u00e1lez-Fern\u00e1ndez, R. R., Torres-Velasco, M. E., Ichikawa-Escamilla, E., Arce-Sillas, A., Mart\u00ednez-Mart\u00ednez, E., Miranda-Narvaez, C. L., Rodr\u00edguez-Ram\u00edrez, J. F., & Adalid-Peralta, L. (2025). Neurodegeneration models in Parkinson\u2019s disease: cellular and molecular paths to neuron death. Behavioral and Brain Functions, 21(1), Article 14. https:\/\/doi.org\/10.1186\/s12993-025-00279-w","journal-title":"Behavioral and Brain Functions"},{"issue":"7","key":"8925_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/cjpp-2016-0158","volume":"95","author":"AM Ameen","year":"2017","unstructured":"Ameen, A. M., Elkazaz, A. Y., Mohammad, H. M. F., & Barakat, B. M. (2017). Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats. Canadian Journal of Physiology and Pharmacology, 95(7), 819\u2013829. https:\/\/doi.org\/10.1139\/cjpp-2016-0158","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"2","key":"8925_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12017-015-8343-0","volume":"17","author":"SN Amin","year":"2015","unstructured":"Amin, S. N., El-Aidi, A. A., Ali, M. M., Attia, Y. M., & Rashed, L. A. (2015). Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior. Neuromolecular Medicine, 17(2), 121\u2013136. https:\/\/doi.org\/10.1007\/s12017-015-8343-0","journal-title":"Neuromolecular Medicine"},{"key":"8925_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2025.2586129","author":"AS Bahashwan","year":"2025","unstructured":"Bahashwan, A. S., El-Shoura, E. A. M., Saad, H. M., & Zaafar, D. (2025a). Naftidrofuryl mitigates LPS-induced pulmonary injury through macrophage polarization and NLRP3\/TLR4 regulation, an in vitro and in vivo perspective. Immunopharmacology and Immunotoxicology. https:\/\/doi.org\/10.1080\/08923973.2025.2586129","journal-title":"Immunopharmacology and Immunotoxicology"},{"issue":"6","key":"8925_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/08923973.2025.2586129","volume":"47","author":"AS Bahashwan","year":"2025","unstructured":"Bahashwan, A. S., El-Shoura, E. A. M., Saad, H. M., & Zaafar, D. (2025b). Naftidrofuryl mitigates LPS-induced pulmonary injury through macrophage polarization and NLRP3\/TLR4 regulation, an in vitro and in vivo perspective. Immunopharmacology and Immunotoxicology, 47(6), 859\u2013871. https:\/\/doi.org\/10.1080\/08923973.2025.2586129","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"8925_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball, N., Teo, W. P., Chandra, S., & Chapman, J. (2019). Parkinson\u2019s disease and the environment. Frontiers in Neurology, 10, Article 218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Frontiers in Neurology"},{"key":"8925_CR10","volume-title":"Theory and practice of histological techniques: Elsevier health sciences","author":"JD Bancroft","year":"2008","unstructured":"Bancroft, J. D., & Gamble, M. (2008). Theory and practice of histological techniques: Elsevier health sciences."},{"issue":"2","key":"8925_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2003.12.005","volume":"186","author":"V Bashkatova","year":"2004","unstructured":"Bashkatova, V., Alam, M., Vanin, A., & Schmidt, W. J. (2004). Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Experimental Neurology, 186(2), 235\u2013241. https:\/\/doi.org\/10.1016\/j.expneurol.2003.12.005","journal-title":"Experimental Neurology"},{"issue":"12","key":"8925_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304180","volume":"13","author":"M Battaglini","year":"2024","unstructured":"Battaglini, M., Marino, A., Montorsi, M., Carmignani, A., Ceccarelli, M. C., & Ciofani, G. (2024). Nanomaterials as microglia modulators in the treatment of central nervous system disorders. Advanced Healthcare Materials, 13(12), Article e2304180. https:\/\/doi.org\/10.1002\/adhm.202304180","journal-title":"Advanced Healthcare Materials"},{"issue":"5","key":"8925_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1148\/rg.345140009","volume":"34","author":"SM Broski","year":"2014","unstructured":"Broski, S. M., Hunt, C. H., Johnson, G. B., Morreale, R. F., Lowe, V. J., & Peller, P. J. (2014). Structural and functional imaging in parkinsonian syndromes. Radiographics, 34(5), 1273\u20131292. https:\/\/doi.org\/10.1148\/rg.345140009","journal-title":"Radiographics"},{"issue":"11","key":"8925_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/tx049867r","volume":"17","author":"P Caboni","year":"2004","unstructured":"Caboni, P., Sherer, T. B., Zhang, N., Taylor, G., Na, H. M., Greenamyre, J. T., & Casida, J. E. (2004). Rotenone, deguelin, their metabolites, and the rat model of Parkinson\u2019s disease. Chemical Research in Toxicology, 17(11), 1540\u20131548. https:\/\/doi.org\/10.1021\/tx049867r","journal-title":"Chemical Research in Toxicology"},{"issue":"3-4","key":"8925_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0891-5849(00)00317-8","volume":"29","author":"E Cadenas","year":"2000","unstructured":"Cadenas, E., & Davies, K. J. (2000). Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biology & Medicine, 29(3\u20134), 222\u2013230. https:\/\/doi.org\/10.1016\/s0891-5849(00)00317-8","journal-title":"Free Radical Biology & Medicine"},{"key":"8925_CR16","doi-asserted-by":"publisher","DOI":"10.3791\/3769","volume":"59","author":"A Can","year":"2012","unstructured":"Can, A., Dao, D. T., Terrillion, C. E., Piantadosi, S. C., Bhat, S., & Gould, T. D. (2012). The tail suspension test. Journal of Visualized Experiments, 59, Article e3769. https:\/\/doi.org\/10.3791\/3769","journal-title":"Journal of Visualized Experiments"},{"issue":"3","key":"8925_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/jpd-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L., & Blandini, F. (2019). Parkinson\u2019s disease in women and men: What\u2019s the difference? Journal of Parkinson\u2019s Disease, 9(3), 501\u2013515. https:\/\/doi.org\/10.3233\/jpd-191683","journal-title":"Journal of Parkinson's Disease"},{"key":"8925_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642900","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen, L., Huang, Y., Yu, X., Lu, J., Jia, W., Song, J., Liu, L., Wang, Y., Xie, J., & Li, M. (2021). Corynoxine protects dopaminergic neurons through inducing autophagy and diminishing neuroinflammation in rotenone-induced animal models of Parkinson\u2019s disease. Frontiers in Pharmacology, 12, Article 642900. https:\/\/doi.org\/10.3389\/fphar.2021.642900","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"8925_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12640-021-00451-w","volume":"40","author":"CN Chen","year":"2022","unstructured":"Chen, C. N., Wang, M. H., Soung, H. S., Chen, S. M., Fang, C. H., Lin, Y. W., & Tseng, H. C. (2022). (L)-Theanine ameliorated rotenone-induced Parkinsonism-like symptoms in rats. Neurotoxicity Research, 40(1), 241\u2013258. https:\/\/doi.org\/10.1007\/s12640-021-00451-w","journal-title":"Neurotoxicity Research"},{"key":"8925_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00124","volume":"9","author":"M Chin-Chan","year":"2015","unstructured":"Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015). Environmental pollutants as risk factors for neurodegenerative disorders: alzheimer and Parkinson diseases. Frontiers in Cellular Neuroscience, 9, Article 124. https:\/\/doi.org\/10.3389\/fncel.2015.00124","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"3 Suppl","key":"8925_CR21","doi-asserted-by":"publisher","first-page":"2s","DOI":"10.1016\/j.jvs.2014.12.009","volume":"61","author":"MS Conte","year":"2015","unstructured":"Conte, M. S., Pomposelli, F. B., Clair, D. G., Geraghty, P. J., McKinsey, J. F., Mills, J. L., Moneta, G. L., Murad, M. H., Powell, R. J., Reed, A. B., Schanzer, A., & Sidawy, A. N. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. Journal of Vascular Surgery, 61(3 Suppl), 2s\u201341s. https:\/\/doi.org\/10.1016\/j.jvs.2014.12.009","journal-title":"Journal of Vascular Surgery"},{"key":"8925_CR22","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3465","author":"AR Crowe","year":"2019","unstructured":"Crowe, A. R., & Yue, W. (2019). Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio-Protocol. https:\/\/doi.org\/10.21769\/BioProtoc.3465","journal-title":"Bio-Protocol"},{"issue":"9b","key":"8925_CR23","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1111\/j.1582-4934.2008.00443.x","volume":"13","author":"N Dehvari","year":"2009","unstructured":"Dehvari, N., Sandebring, A., Flores-Morales, A., Mateos, L., Chuan, Y. C., Goldberg, M. S., & Cedazo-M\u00ednguez, A. (2009). Parkin-mediated ubiquitination regulates phospholipase C-gamma1. Journal of Cellular and Molecular Medicine, 13(9b), 3061\u20133068. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00443.x","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"Suppl 1(Suppl 1","key":"8925_CR24","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. (2018). Neuropathology of Parkinson disease. Parkinsonism & Related Disorders, 46(Suppl 1(Suppl 1)), S30-s33. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism & Related Disorders"},{"key":"8925_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109967","volume":"125","author":"Z Do\u011fanyi\u011fit","year":"2020","unstructured":"Do\u011fanyi\u011fit, Z., Okan, A., Kaymak, E., Pand\u0131r, D., & Silici, S. (2020). Investigation of protective effects of apilarnil against lipopolysaccharide induced liver injury in rats via TLR 4\/ HMGB-1\/ NF-\u03baB pathway. Biomedicine & Pharmacotherapy, 125, Article 109967. https:\/\/doi.org\/10.1016\/j.biopha.2020.109967","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"8925_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114917","volume":"164","author":"MH ElSayed","year":"2023","unstructured":"ElSayed, M. H., Atif, H. M., Eladl, M. A., Elaidy, S. M., Helaly, A. M. N., Hisham, F. A., Farag, N. E., Osman, N. M. S., Ibrahiem, A. T., Khella, H. W. Z., Bilasy, S. E., Albalawi, M. A., Helal, M. A., Alzlaiq, W. A., & Zaitone, S. A. (2023). Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4\/MyD88\/NF-\u03baB pathway: Molecular docking and biological investigations. Biomedicine & Pharmacotherapy, 164, Article 114917. https:\/\/doi.org\/10.1016\/j.biopha.2023.114917","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"8925_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuro.2019.03.005","volume":"73","author":"EO Farombi","year":"2019","unstructured":"Farombi, E. O., Awogbindin, I. O., Farombi, T. H., Oladele, J. O., Izomoh, E. R., Aladelokun, O. B., Ezekiel, I. O., Adebambo, O. I., & Abah, V. O. (2019). Neuroprotective role of kolaviron in striatal redo-inflammation associated with Rotenone model of Parkinson\u2019s disease. Neurotoxicology, 73, 132\u2013141. https:\/\/doi.org\/10.1016\/j.neuro.2019.03.005","journal-title":"Neurotoxicology"},{"issue":"3","key":"8925_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/neuroglia6030036","volume":"6","author":"MAM Freire","year":"2025","unstructured":"Freire, M. A. M., Rocha, G. S., Lemos, N. A. M., Lima, R. R., Bittar, S., Jenkins, L. B., Falcao, D., Steinbusch, H. W. M., & Santos, J. R. (2025). Insights into Parkinson\u2019s Disease pathology focusing on glial response and apoptosis in a classic rat model of dopaminergic degeneration. Neuroglia, 6(3), Article 36.","journal-title":"Neuroglia"},{"issue":"2","key":"8925_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12017-019-08590-2","volume":"22","author":"D Garabadu","year":"2020","unstructured":"Garabadu, D., & Agrawal, N. (2020). Naringin exhibits neuroprotection against Rotenone-induced neurotoxicity in experimental rodents. Neuromolecular Medicine, 22(2), 314\u2013330. https:\/\/doi.org\/10.1007\/s12017-019-08590-2","journal-title":"Neuromolecular Medicine"},{"issue":"1","key":"8925_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1538574420953944","volume":"55","author":"F G\u00fcla\u015ft\u0131 \u00d6","year":"2021","unstructured":"G\u00fcla\u015ft\u0131 \u00d6, F., Yavuz, \u015e, Ar\u0131kan, A. A., Eraldemir, F. C., \u00d6zbudak, E., \u015eahin, D., & K\u0131r, H. M. (2021). Comparison of Cilostazol and Naftidrofuryl in an experimental acute ischemia-reperfusion model. Vascular and Endovascular Surgery, 55(1), 11\u201317. https:\/\/doi.org\/10.1177\/1538574420953944","journal-title":"Vascular and Endovascular Surgery"},{"key":"8925_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neulet.2019.01.057","volume":"699","author":"C G\u00fcnayd\u0131n","year":"2019","unstructured":"G\u00fcnayd\u0131n, C., Avc\u0131, B., Bozkurt, A., \u00d6nger, M. E., Balc\u0131, H., & Bilge, S. S. (2019). Effects of agomelatine in Rotenone-induced Parkinson\u2019s disease in rats. Neuroscience Letters, 699, 71\u201376. https:\/\/doi.org\/10.1016\/j.neulet.2019.01.057","journal-title":"Neuroscience Letters"},{"key":"8925_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.109922","volume":"81","author":"S Gupta","year":"2021","unstructured":"Gupta, S., Mishra, A., & Singh, S. (2021). Cardinal role of eukaryotic initiation factor 2 (eIF2\u03b1) in progressive dopaminergic neuronal death & DNA fragmentation: implication of PERK:IRE1\u03b1:ATF6 axis in Parkinson\u2019s pathology. Cellular Signalling, 81, Article 109922. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109922","journal-title":"Cellular Signalling"},{"key":"8925_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019). Neuroinflammation as a common feature of neurodegenerative disorders. Frontiers in Pharmacology, 10, Article 1008. https:\/\/doi.org\/10.3389\/fphar.2019.01008","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"8925_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/2772270816666220105124730","volume":"15","author":"S Hadjira","year":"2022","unstructured":"Hadjira, S., Mansour, A., Seghiri, R., Menad, A., Benayache, F., Benayache, S., & Ameddah, S. (2022). Neuroinflammation and behavioral deficit in rotenone-induced neurotoxicity in rats and the possible effects of butanolic extract of Centaurea africana. Recent Patents on Inflammation & Allergy Drug Discovery, 15(1), 35\u201343. https:\/\/doi.org\/10.2174\/2772270816666220105124730","journal-title":"Recent Patents on Inflammation & Allergy Drug Discovery"},{"key":"8925_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/1-4020-5688-5_12","volume":"42","author":"A Hald","year":"2007","unstructured":"Hald, A., Van Beek, J., & Lotharius, J. (2007). Inflammation in Parkinson\u2019s disease: causative or epiphenomenal? Subcellular Biochemistry, 42, 249\u2013279.","journal-title":"Subcellular Biochemistry"},{"issue":"3","key":"8925_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s12035-013-8466-y","volume":"48","author":"YY He","year":"2013","unstructured":"He, Y. Y., Zhang, X. Y., Yung, W. H., Zhu, J. N., & Wang, J. J. (2013). Role of BDNF in central motor structures and motor diseases. Molecular Neurobiology, 48(3), 783\u2013793. https:\/\/doi.org\/10.1007\/s12035-013-8466-y","journal-title":"Molecular Neurobiology"},{"key":"8925_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111024","volume":"215","author":"S He","year":"2024","unstructured":"He, S., Ru, Q., Chen, L., Xu, G., & Wu, Y. (2024). Advances in animal models of Parkinson\u2019s disease. Brain Research Bulletin, 215, Article 111024. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111024","journal-title":"Brain Research Bulletin"},{"key":"8925_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2024.109997","volume":"284","author":"A Hemanth Babu","year":"2024","unstructured":"Hemanth Babu, A., Prasanth, D., Yaraguppi, D. A., Panda, S. P., Ahmad, S. F., Al-Mazroua, H. A., Prasanth, D. S. N. B. K., Sai, A. R., & Praveen Kumar, P. (2024). Antiparkinson potential of khellin on rotenone-induced Parkinson\u2019s disease in a zebrafish model: targeting MAO, inflammatory, and oxidative stress markers with molecular docking, MD simulations, and histopathology evidence. Comparative Biochemistry and Physiology. Part C, Toxicology & Pharmacology, 284, Article 109997. https:\/\/doi.org\/10.1016\/j.cbpc.2024.109997","journal-title":"Comparative Biochemistry and Physiology. Part C, Toxicology & Pharmacology"},{"issue":"3","key":"8925_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neuro.2012.01.018","volume":"33","author":"MC Hern\u00e1ndez-Romero","year":"2012","unstructured":"Hern\u00e1ndez-Romero, M. C., Delgado-Cort\u00e9s, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Arg\u00fcelles, S., B\u00e1ndez, M. J., Villar\u00e1n, R. F., Mauri\u00f1o, R., Santiago, M., Venero, J. L., Herrera, A. J., Cano, J., & Machado, A. (2012). Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Neurotoxicology, 33(3), 347\u2013360. https:\/\/doi.org\/10.1016\/j.neuro.2012.01.018","journal-title":"Neurotoxicology"},{"issue":"4","key":"8925_CR41","first-page":"412","volume":"34","author":"S Hoyer","year":"1984","unstructured":"Hoyer, S. (1984). The effect of naftidrofuryl on cyanide-induced hypoxic damage to glucose and energy metabolism in brain cortex of rats. Arzneimittel-Forschung, 34(4), 412\u2013416.","journal-title":"Arzneimittel-Forschung"},{"issue":"1","key":"8925_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang, O. (2013). Role of oxidative stress in Parkinson\u2019s disease. Experimental Neurobiology, 22(1), 11\u201317. https:\/\/doi.org\/10.5607\/en.2013.22.1.11","journal-title":"Experimental Neurobiology"},{"issue":"4","key":"8925_CR43","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez, M. T., Serrano-Garc\u00eda, N., & Orozco-Ibarra, M. (2023). Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. Molecular Neurobiology, 60(4), 1929\u20131948. https:\/\/doi.org\/10.1007\/s12035-022-03193-8","journal-title":"Molecular Neurobiology"},{"issue":"13","key":"8925_CR44","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1074\/jbc.M510926200","volume":"281","author":"H Jiang","year":"2006","unstructured":"Jiang, H., Jiang, Q., Liu, W., & Feng, J. (2006). Parkin suppresses the expression of monoamine oxidases. Journal of Biological Chemistry, 281(13), 8591\u20138599. https:\/\/doi.org\/10.1074\/jbc.M510926200","journal-title":"Journal of Biological Chemistry"},{"key":"8925_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson, M. E., & Bobrovskaya, L. (2015). An update on the Rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology, 46, 101\u2013116. https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","journal-title":"Neurotoxicology"},{"key":"8925_CR46","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/985085","volume":"2011","author":"K Kanninen","year":"2011","unstructured":"Kanninen, K., White, A. R., Koistinaho, J., & Malm, T. (2011). Targeting Glycogen Synthase Kinase-3\u03b2 for therapeutic benefit against oxidative stress in Alzheimer\u2019s disease: involvement of the Nrf2-ARE pathway. International Journal of Alzheimer\u2019s Disease, 2011, Article 985085. https:\/\/doi.org\/10.4061\/2011\/985085","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"issue":"5","key":"8925_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/19390211.2016.1275916","volume":"14","author":"YA Khadrawy","year":"2017","unstructured":"Khadrawy, Y. A., Salem, A. M., El-Shamy, K. A., Ahmed, E. K., Fadl, N. N., & Hosny, E. N. (2017). Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson\u2019s disease induced by Rotenone. Journal of Dietary Supplements, 14(5), 553\u2013572. https:\/\/doi.org\/10.1080\/19390211.2016.1275916","journal-title":"Journal of Dietary Supplements"},{"key":"8925_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175300","volume":"934","author":"M Khot","year":"2022","unstructured":"Khot, M., Sood, A., Tryphena, K. P., Khan, S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022). NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson\u2019s disease. European Journal of Pharmacology, 934, Article 175300. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175300","journal-title":"European Journal of Pharmacology"},{"key":"8925_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni, A., Preeti, K., Tryphena, K. P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023). Proteostasis in Parkinson\u2019s disease: Recent development and possible implication in diagnosis and therapeutics. Ageing Research Reviews, 84, Article 101816. https:\/\/doi.org\/10.1016\/j.arr.2022.101816","journal-title":"Ageing Research Reviews"},{"key":"8925_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2022.100209","volume":"6","author":"S Kumar","year":"2023","unstructured":"Kumar, S., Kumar, S., Arthur, R., & Kumar, P. (2023). Trans-cinnamaldehyde mitigates rotenone-induced neurotoxicity via inhibiting oxidative stress in rats. Pharmacological Research - Modern Chinese Medicine, 6, Article 100209. https:\/\/doi.org\/10.1016\/j.prmcm.2022.100209","journal-title":"Pharmacological Research - Modern Chinese Medicine"},{"issue":"2","key":"8925_CR51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13275","volume":"13","author":"M Kumaresan","year":"2021","unstructured":"Kumaresan, M., & Khan, S. (2021). Spectrum of non-motor symptoms in Parkinson\u2019s disease. Cureus, 13(2), Article e13275. https:\/\/doi.org\/10.7759\/cureus.13275","journal-title":"Cureus"},{"issue":"5","key":"8925_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","volume":"42","author":"Y Lee","year":"2019","unstructured":"Lee, Y., Lee, S., Chang, S. C., & Lee, J. (2019). Significant roles of neuroinflammation in Parkinson\u2019s disease: Therapeutic targets for PD prevention. Archives of Pharmacal Research, 42(5), 416\u2013425. https:\/\/doi.org\/10.1007\/s12272-019-01133-0","journal-title":"Archives of Pharmacal Research"},{"issue":"4","key":"8925_CR53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25(4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"1","key":"8925_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1750-3639.1999.tb00214.x","volume":"9","author":"S Love","year":"1999","unstructured":"Love, S. (1999). Oxidative stress in brain ischemia. Brain Pathology, 9(1), 119\u2013131. https:\/\/doi.org\/10.1111\/j.1750-3639.1999.tb00214.x","journal-title":"Brain Pathology"},{"issue":"5","key":"8925_CR55","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4103\/0028-3886.294542","volume":"68","author":"K Manasa","year":"2020","unstructured":"Manasa, K., Chitra, V., & Tamilanban, T. (2020). Teleost model as an alternative in Parkinson\u2019s Disease. Neurology India, 68(5), 979\u2013984. https:\/\/doi.org\/10.4103\/0028-3886.294542","journal-title":"Neurology India"},{"issue":"2","key":"8925_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(85)80613-x","volume":"184","author":"SL Marklund","year":"1985","unstructured":"Marklund, S. L. (1985). Product of extracellular-superoxide dismutase catalysis. FEBS Letters, 184(2), 237\u2013239. https:\/\/doi.org\/10.1016\/0014-5793(85)80613-x","journal-title":"FEBS Letters"},{"issue":"3","key":"8925_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","volume":"19","author":"G Mercado","year":"2013","unstructured":"Mercado, G., Vald\u00e9s, P., & Hetz, C. (2013). An ERcentric view of Parkinson\u2019s disease. Trends in Molecular Medicine, 19(3), 165\u2013175. https:\/\/doi.org\/10.1016\/j.molmed.2012.12.005","journal-title":"Trends in Molecular Medicine"},{"issue":"3","key":"8925_CR58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/micr.1920150308","volume":"15","author":"M Merle","year":"1994","unstructured":"Merle, M., Gilbert, A., Fredenucci, J. F., Petry, D., Foliguet, B., & Mosnier, M. (1994). Experimental and clinical study of the effect of naftidrofuryl on the recovery from peripheral nerve lesions. Microsurgery, 15(3), 179\u2013186. https:\/\/doi.org\/10.1002\/micr.1920150308","journal-title":"Microsurgery"},{"issue":"1","key":"8925_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Mihara","year":"1978","unstructured":"Mihara, M., & Uchiyama, M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86(1), 271\u2013278. https:\/\/doi.org\/10.1016\/0003-2697(78)90342-1","journal-title":"Analytical Biochemistry"},{"issue":"1\u20132","key":"8925_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0091-3057(01)00636-0","volume":"71","author":"K Mizoguchi","year":"2002","unstructured":"Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H., & Tabira, T. (2002). Chronic stress impairs rotarod performance in rats: Implications for depressive state. Pharmacology, Biochemistry and Behavior, 71(1\u20132), 79\u201384. https:\/\/doi.org\/10.1016\/s0091-3057(01)00636-0","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"8925_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110002","volume":"362","author":"TK Motawi","year":"2022","unstructured":"Motawi, T. K., Al-Kady, R. H., Abdelraouf, S. M., & Senousy, M. A. (2022). Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson\u2019s Disease in rats: Targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p. Chemico-Biological Interactions, 362, Article 110002. https:\/\/doi.org\/10.1016\/j.cbi.2022.110002","journal-title":"Chemico-Biological Interactions"},{"issue":"1","key":"8925_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1021\/acschemneuro.2c00656","volume":"14","author":"TK Motawi","year":"2023","unstructured":"Motawi, T. K., Al-Kady, R. H., Senousy, M. A., & Abdelraouf, S. M. (2023). Repaglinide elicits a neuroprotective effect in rotenone-induced Parkinson\u2019s Disease in rats: Emphasis on targeting the DREAM-ER stress BiP\/ATF6\/CHOP trajectory and activation of mitophagy. ACS Chemical Neuroscience, 14(1), 180\u2013194. https:\/\/doi.org\/10.1021\/acschemneuro.2c00656","journal-title":"ACS Chemical Neuroscience"},{"issue":"5","key":"8925_CR63","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/mds.28922","volume":"37","author":"H Murata","year":"2022","unstructured":"Murata, H., Barnhill, L. M., & Bronstein, J. M. (2022). Air pollution and the risk of Parkinson\u2019s Disease: A review. Movement Disorders, 37(5), 894\u2013904. https:\/\/doi.org\/10.1002\/mds.28922","journal-title":"Movement Disorders"},{"issue":"4","key":"8925_CR64","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0091-3057(91)90065-a","volume":"39","author":"S Ogawa","year":"1991","unstructured":"Ogawa, S., Kameyama, T., & Nabeshima, T. (1991). Naftidrofuryl oxalate, nootropic effects on the scopolamine- and the basal forebrain lesion-induced amnesia in rats. Pharmacology, Biochemistry and Behavior, 39(4), 997\u20131002. https:\/\/doi.org\/10.1016\/0091-3057(91)90065-a","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"8925_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang, S. Y., Ho, P. W., Liu, H. F., Leung, C. T., Li, L., Chang, E. E. S., Pang, S.-Y., Ho, P.-L., Ramsden, D. B., & Ho, S. L. (2019). The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s Disease. Translational Neurodegeneration, 8, Article 23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Translational Neurodegeneration"},{"issue":"17","key":"8925_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178335","volume":"26","author":"F Panvino","year":"2025","unstructured":"Panvino, F., Paparella, R., Tarani, F., Lombardi, C., Ferraguti, G., Pisani, F., Fiore, M., Pancheva, R., Ardizzone, I., & Tarani, L. (2025). Neurotrophins in neurodevelopmental disorders: A narrative review of the literature. International Journal of Molecular Sciences, 26(17), Article 8335.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"8925_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15050172","volume":"15","author":"L Pe\u00f1a-Zelayeta","year":"2025","unstructured":"Pe\u00f1a-Zelayeta, L., Delgado-Minjares, K. M., Villegas-Rojas, M. M., Le\u00f3n-Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., P\u00e9rez-Segura, I., Ortega-Robles, E., Soto-Rojas, L. O., & Arias-Carri\u00f3n, O. (2025). Redefining non-motor symptoms in Parkinson\u2019s Disease. Journal of Personalized Medicine, 15(5), Article 172. https:\/\/doi.org\/10.3390\/jpm15050172","journal-title":"Journal of Personalized Medicine"},{"issue":"2","key":"8925_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12640-018-9957-4","volume":"35","author":"K Peng","year":"2019","unstructured":"Peng, K., Xiao, J., Yang, L., Ye, F., Cao, J., & Sai, Y. (2019). Mutual antagonism of PINK1\/Parkin and PGC-1\u03b1 contributes to maintenance of mitochondrial homeostasis in rotenone-induced neurotoxicity. Neurotoxicity Research, 35(2), 331\u2013343. https:\/\/doi.org\/10.1007\/s12640-018-9957-4","journal-title":"Neurotoxicity Research"},{"issue":"1","key":"8925_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-020-02451-y","volume":"16","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., MacCallum, C. J., Macleod, M., \u2026 W\u00fcrbel, H. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Veterinary Research, 16(1), Article 242. https:\/\/doi.org\/10.1186\/s12917-020-02451-y","journal-title":"BMC Veterinary Research"},{"key":"8925_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd5575","author":"T Phongpreecha","year":"2020","unstructured":"Phongpreecha, T., Fernandez, R., Mrdjen, D., Culos, A., Gajera, C. R., Wawro, A. M., Stanley, N., Gaudilliere, B., Poston, K. L., Aghaeepour, N., & Montine, T. J. (2020). Single-cell peripheral immunoprofiling of Alzheimer\u2019s and Parkinson\u2019s diseases. Science Advances. https:\/\/doi.org\/10.1126\/sciadv.abd5575","journal-title":"Science Advances"},{"issue":"4","key":"8925_CR71","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1523\/jneurosci.1384-17.2017","volume":"38","author":"M Pinto","year":"2018","unstructured":"Pinto, M., Nissanka, N., & Moraes, C. T. (2018). Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson\u2019s disease. Journal of Neuroscience, 38(4), 1042\u20131053. https:\/\/doi.org\/10.1523\/jneurosci.1384-17.2017","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"8925_CR72","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1073\/pnas.0709336105","volume":"105","author":"AC Poole","year":"2008","unstructured":"Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008). The PINK1\/Parkin pathway regulates mitochondrial morphology. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1638\u20131643. https:\/\/doi.org\/10.1073\/pnas.0709336105","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8925_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan, S., Tryphena, K. P., Khan, S., Vora, L., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023). Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Research Reviews, 87, Article 101915. https:\/\/doi.org\/10.1016\/j.arr.2023.101915","journal-title":"Ageing Research Reviews"},{"key":"8925_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107900","volume":"164","author":"RM Salama","year":"2020","unstructured":"Salama, R. M., Abdel-Latif, G. A., Abbas, S. S., El Magdoub, H. M., & Schaalan, M. F. (2020). Neuroprotective effect of crocin against rotenone-induced Parkinson\u2019s disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology, 164, Article 107900. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900","journal-title":"Neuropharmacology"},{"key":"8925_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112536","volume":"137","author":"RM Salama","year":"2024","unstructured":"Salama, R. M., Darwish, S. F., Yehia, R., Eissa, N., Elmongy, N. F., Abd-Elgalil, M. M., Schaalan, M. F., & El Wakeel, S. A. (2024). Apilarnil exerts neuroprotective effects and alleviates motor dysfunction by rebalancing M1\/M2 microglia polarization, regulating miR-155 and miR-124 expression in a rotenone-induced Parkinson\u2019s disease rat model. International Immunopharmacology, 137, Article 112536. https:\/\/doi.org\/10.1016\/j.intimp.2024.112536","journal-title":"International Immunopharmacology"},{"issue":"9","key":"8925_CR76","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1007\/s00210-025-03920-7","volume":"398","author":"EA Salem","year":"2025","unstructured":"Salem, E. A., Alqahtani, S. M., El-Shoura, E. A. M., Zaghlool, S. S., Abdelzaher, L. A., Mohamed, S. A. M., Alalhareth, I. S., & Sheref, A. A. M. (2025). Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 398(9), 11919\u201311931. https:\/\/doi.org\/10.1007\/s00210-025-03920-7","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"1","key":"8925_CR77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak, J., & Lindsay, R. H. (1968). Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Analytical Biochemistry, 25(1), 192\u2013205. https:\/\/doi.org\/10.1016\/0003-2697(68)90092-4","journal-title":"Analytical Biochemistry"},{"issue":"34","key":"8925_CR78","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/jneurosci.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003). Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. Journal of Neuroscience, 23(34), 10756\u201310764. https:\/\/doi.org\/10.1523\/jneurosci.23-34-10756.2003","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"8925_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12263-007-0063-0","volume":"2","author":"YJ Surh","year":"2008","unstructured":"Surh, Y. J., & Na, H. K. (2008). NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes & Nutrition, 2(4), 313\u2013317. https:\/\/doi.org\/10.1007\/s12263-007-0063-0","journal-title":"Genes & Nutrition"},{"key":"8925_CR80","doi-asserted-by":"crossref","unstructured":"Syed, N. A., Albert, D. M., Garner, A., & White, V. A. (2022). General Principles of Ophthalmic Pathology. In Albert and Jakobiec\u2019s Principles and Practice of Ophthalmology (pp. 5905\u20135963): Springer","DOI":"10.1007\/978-3-030-42634-7_126"},{"issue":"1","key":"8925_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1476-5381.1996.tb15363.x","volume":"118","author":"N Takagi","year":"1996","unstructured":"Takagi, N., Miyake, K., Ohiwa, A., Nukaga, R., & Takeo, S. (1996). Effects of delayed treatment with nafronyl oxalate on microsphere embolism-induced changes in monoamine levels of rat brain regions. British Journal of Pharmacology, 118(1), 33\u201340. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15363.x","journal-title":"British Journal of Pharmacology"},{"issue":"11","key":"8925_CR82","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022). Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology, 22(11), 657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"8925_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12035-014-8769-7","volume":"51","author":"P Thakur","year":"2015","unstructured":"Thakur, P., & Nehru, B. (2015). Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson\u2019s disease. Molecular Neurobiology, 51(1), 209\u2013219. https:\/\/doi.org\/10.1007\/s12035-014-8769-7","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"8925_CR84","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1292\/jvms.19-0502","volume":"82","author":"N Tomita","year":"2020","unstructured":"Tomita, N., Nakamura, T., Sunden, Y., & Morita, T. (2020). Histopathological and immunohistochemical analysis of the cerebral white matter after transient hypoglycemia in rat. Journal of Veterinary Medical Science, 82(1), 68\u201376. https:\/\/doi.org\/10.1292\/jvms.19-0502","journal-title":"Journal of Veterinary Medical Science"},{"issue":"3","key":"8925_CR85","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12640-019-00143-6","volume":"37","author":"HC Tseng","year":"2020","unstructured":"Tseng, H. C., Wang, M. H., Chang, K. C., Soung, H. S., Fang, C. H., Lin, Y. W., & Tsai, C. C. (2020). Protective effect of (-)epigallocatechin-3-gallate on rotenone-induced parkinsonism-like symptoms in rats. Neurotoxicity Research, 37(3), 669\u2013682. https:\/\/doi.org\/10.1007\/s12640-019-00143-6","journal-title":"Neurotoxicity Research"},{"issue":"1","key":"8925_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70133","volume":"39","author":"N \u00dcremi\u015f","year":"2025","unstructured":"\u00dcremi\u015f, N., & \u00dcremi\u015f, M. M. (2025). Oxidative\/Nitrosative stress, apoptosis, and redox signaling: Key players in neurodegenerative diseases. Journal of Biochemical and Molecular Toxicology, 39(1), Article e70133. https:\/\/doi.org\/10.1002\/jbt.70133","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"1","key":"8925_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00561-6","volume":"9","author":"AD Van Laar","year":"2023","unstructured":"Van Laar, A. D., Webb, K. R., Keeney, M. T., Van Laar, V. S., Zharikov, A., Burton, E. A., Hastings, T. G., Glajch, K. E., Hirst, W. D., Greenamyre, J. T., & Rocha, E. M. (2023). Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy. Npj Parkinson\u2019s Disease, 9(1), Article 121. https:\/\/doi.org\/10.1038\/s41531-023-00561-6","journal-title":"Npj Parkinson's Disease"},{"key":"8925_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2010.00012","volume":"2","author":"X Wang","year":"2010","unstructured":"Wang, X., & Michaelis, E. K. (2010). Selective neuronal vulnerability to oxidative stress in the brain. Frontiers in Aging Neuroscience, 2, Article 12. https:\/\/doi.org\/10.3389\/fnagi.2010.00012","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"8925_CR89","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00005344-199302000-00021","volume":"21","author":"AA Weber","year":"1993","unstructured":"Weber, A. A., Hohlfeld, T., Strobach, H., & Schr\u00f6r, K. (1993). Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits. Journal of Cardiovascular Pharmacology, 21(2), 332\u2013338. https:\/\/doi.org\/10.1097\/00005344-199302000-00021","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"18","key":"8925_CR90","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2174\/138161207780858429","volume":"13","author":"H Wilms","year":"2007","unstructured":"Wilms, H., Zecca, L., Rosenstiel, P., Sievers, J., Deuschl, G., & Lucius, R. (2007). Inflammation in Parkinson\u2019s diseases and other neurodegenerative diseases: cause and therapeutic implications. Current Pharmaceutical Design, 13(18), 1925\u20131928. https:\/\/doi.org\/10.2174\/138161207780858429","journal-title":"Current Pharmaceutical Design"},{"key":"8925_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.114630","volume":"252","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Xie, Z., Peng, Y., Xie, A., Fu, C., Zheng, D., Cai, ZiWei, Zhong, J., Ming, Q., Li, M., Lu, R., Liu, X., & Chen, J. (2023). PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration. Ecotoxicology and Environmental Safety, 252, Article 114630. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114630","journal-title":"Ecotoxicology and Environmental Safety"},{"key":"8925_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112247","volume":"134","author":"T Zhao","year":"2024","unstructured":"Zhao, T., Zhang, X., Cui, X., Su, S., Li, L., Chen, Y., Wang, N., Sun, L., Zhao, J., Zhang, J., Han, X., & Cao, J. (2024). Oridonin exerts anticonvulsant profile and neuroprotective activity in epileptic mice by inhibiting NLRP3-mediated pyroptosis. International Immunopharmacology, 134, Article 112247. https:\/\/doi.org\/10.1016\/j.intimp.2024.112247","journal-title":"International Immunopharmacology"},{"issue":"Pt 3","key":"8925_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113608","volume":"143","author":"D Zheng","year":"2024","unstructured":"Zheng, D., Lai, Y., Huang, K., Guan, D., Xie, Z., Fu, C., Liu, L., Huang, J., Gong, L., Li, J., Zhang, H., & Chen, J. (2024). Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson\u2019s disease induced by rotenone. International Immunopharmacology, 143(Pt 3), Article 113608. https:\/\/doi.org\/10.1016\/j.intimp.2024.113608","journal-title":"International Immunopharmacology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-026-08925-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-026-08925-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-026-08925-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:28:08Z","timestamp":1776720488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-026-08925-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8925"],"URL":"https:\/\/doi.org\/10.1007\/s12017-026-08925-w","relation":{},"ISSN":["1559-1174"],"issn-type":[{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"All experimental procedures were fully approved by the Ethics Committee for Animal Experiments of the Faculty of Pharmacy, Al-Azhar University, Assiut branch (Approval ID: (AZ-AS\/PH-REC\/25\/2025). The animal care and experiments adhered to internationally recognized standards for the care and use of laboratory animals, outlined in the US National Institutes of Health guidelines (NIH publication #85\u201323, revised in 1985), and complied with the Egyptian Guide for the Care and Use of Laboratory Animals. All procedures followed the ARRIVE guidelines. Great care was taken to minimize the number of animals used and to reduce their discomfort, with gentle handling to avoid unnecessary disturbances, squeezing, pressure, or rough manipulation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"21"}}